Compounds > n-formylmethionine leucyl-phenylalanine

n-formylmethionine leucyl-phenylalanine and Pulmonary Hypertension

n-formylmethionine leucyl-phenylalanine has been researched along with Pulmonary Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haferkamp, O; Kleeberg, S; Rödel, G; Seibold, H; Stauch, M1
Ono, S; Voelkel, NF; Westcott, JY1

Other Studies

2 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Pulmonary Hypertension

ArticleYear
Neutrophilic migration through capillarylike micropores: influence of pulmonary passage.
    The Clinical investigator, 1993, Volume: 72, Issue:1

    Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Angina Pectoris; Cell Movement; Chemotaxis, Leukocyte; Female; Heart Valve Diseases; Heart Ventricles; Humans; Hypertension, Pulmonary; Lung; Male; Microcirculation; Middle Aged; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pulmonary Artery; Pulmonary Circulation; Zymosan

1993
PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
    Journal of applied physiology (Bethesda, Md. : 1985), 1992, Volume: 73, Issue:3

    Topics: Animals; Azepines; Endothelins; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Pulmonary Circulation; Rats; Triazoles; Vasoconstriction

1992